Literature DB >> 17560994

Phospholipase D-dependent and -independent p38MAPK activation pathways are required for superoxide production and chemotactic induction, respectively, in rat neutrophils stimulated by fMLP.

Yukio Azuma1, Keiichi Kosaka, Masanori Kashimata.   

Abstract

Mitogen-activated protein kinase (MAPK)-mediated signal transduction pathways convert signals by extracellular stimulation into a variety of cellular functions. However, the roles of MAPKs in neutrophils are not well understood. To elucidate the temporal roles of p38MAPK during rat neutrophil activation stimulated by N-formyl-methionyl-leucyl-phenylalanine (fMLP), we examined the kinetics of this enzyme and the role of p38MAPK related to neutrophil functions (superoxide production and chemotaxis). SB203580, a potent and specific inhibitor of p38MAPK, significantly depressed both superoxide production and chemotaxis. Ethanol and 1-butanol, inhibitors of phospholipase D (PLD), suppressed p38MAPK activation in neutrophils under conditions (1 microM fMLP for 5 min) that stimulated superoxide production; and they significantly depressed superoxide production in rat neutrophils stimulated by fMLP. However, neither inhibitor had any effect on the activation of p38MAPK under the conditions (10 nM fMLP for 60 min) that gave optimal chemotaxis. These results indicate that multiple signaling pathways were involved in stimulating p38MAPK and that p38MAPK played different roles in regulating neutrophil function depending on the conditions for stimulation with fMLP. In addition, the activation of p38MAPK occurred dependent on or independent of PLD activation in neutrophils stimulated with fMLP.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560994     DOI: 10.1016/j.ejphar.2007.05.001

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Tumor Necrosis Factor α-Dependent Neutrophil Priming Prevents Intestinal Ischemia/Reperfusion-Induced Bacterial Translocation.

Authors:  Yen-Zhen Lu; Ching-Ying Huang; Yi-Cheng Huang; Tsung-Chun Lee; Wei-Ting Kuo; Yu-Chen Pai; Linda Chia-Hui Yu
Journal:  Dig Dis Sci       Date:  2017-01-31       Impact factor: 3.199

2.  Role of curcumin in PLD activation by Arf6-cytohesin1 signaling axis in U46619-stimulated pulmonary artery smooth muscle cells.

Authors:  Sajal Chakraborti; Jaganmay Sarkar; Rajabrata Bhuyan; Tapati Chakraborti
Journal:  Mol Cell Biochem       Date:  2017-08-05       Impact factor: 3.396

3.  Adventitia-derived hydrogen peroxide impairs relaxation of the rat carotid artery via smooth muscle cell p38 mitogen-activated protein kinase.

Authors:  Thomas Cascino; Gabor Csanyi; Imad Al Ghouleh; Augusto C Montezano; Rhian M Touyz; Mounir J Haurani; Patrick J Pagano
Journal:  Antioxid Redox Signal       Date:  2011-04-08       Impact factor: 8.401

4.  Cdk5 mediates vimentin Ser56 phosphorylation during GTP-induced secretion by neutrophils.

Authors:  Ki-Young Lee; Lijuan Liu; Yan Jin; Song-Bin Fu; Jesusa L Rosales
Journal:  J Cell Physiol       Date:  2012-02       Impact factor: 6.384

Review 5.  The regulation of cell motility and chemotaxis by phospholipid signaling.

Authors:  Verena Kölsch; Pascale G Charest; Richard A Firtel
Journal:  J Cell Sci       Date:  2008-03-01       Impact factor: 5.285

Review 6.  Signal-activated phospholipase regulation of leukocyte chemotaxis.

Authors:  Martha K Cathcart
Journal:  J Lipid Res       Date:  2008-12-23       Impact factor: 5.922

7.  Molecular mechanisms of N-formyl-methionyl-leucyl-phenylalanine-induced superoxide generation and degranulation in mouse neutrophils: phospholipase D is dispensable.

Authors:  Takanobu Sato; Tsunaki Hongu; Megumi Sakamoto; Yuji Funakoshi; Yasunori Kanaho
Journal:  Mol Cell Biol       Date:  2012-10-29       Impact factor: 4.272

8.  Neutrophil Extracellular Trap Production in Patients with Colorectal Cancer In Vitro.

Authors:  J J R Richardson; C Hendrickse; F Gao-Smith; D R Thickett
Journal:  Int J Inflam       Date:  2017-07-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.